Clinical Trial Update: Rilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) [Phase 3]

View source ↗

Summary

Phase 3 trial of rilonacept for Cryopyrin-associated periodic syndromes (CAPS) completed with results posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryopyrin-associated Periodic Syndromes
• Familial Cold Autoinflammatory Syndrome
• Familial Cold Urticaria
• Muckle-wells Syndrome

Drugs mentioned

• Arcalyst (rilonacept)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Familial Cold Autoinflammatory Syndrome (FCAS), Familial Cold Urticaria | Phase 3 | Status: COMPLETED | Results posted: 2009-11-13